Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperthyroidism and hepatic dysfunction. A case series analysis.

T L Fong1, J G McHutchison, T B Reynolds

  • 1University of Southern California School of Medicine, Los Angeles.

Journal of Clinical Gastroenterology
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.

Journal of viral hepatitis·2017
Same author

Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis.

Alimentary pharmacology & therapeutics·2016
Same author

Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy.

Alimentary pharmacology & therapeutics·2016
Same author

Antiviral response and resistance analysis of treatment-naïve HCV-infected patients receiving single and multiple doses of GS-9190.

Journal of viral hepatitis·2016
Same author

Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis.

Journal of viral hepatitis·2016
Same journal

GLP-1 Receptor Agonists and Hepatic Encephalopathy in Cirrhosis: A Protective Signal Requiring Cancer and Nutritional Phenotyping.

Journal of clinical gastroenterology·2026
Same journal

Endoscopic Incisional Therapy for Benign Esophageal Strictures: A Systematic Review and Meta-Analysis.

Journal of clinical gastroenterology·2026
Same journal

International Consensus Statements on the Use of Topical Endoscopic Hemostatic Powders in the Treatment of Acute Gastrointestinal Bleeding.

Journal of clinical gastroenterology·2026
Same journal

Do Risk Factors for Reflux Symptoms After Peroral Endoscopic Myotomy Necessarily Increase the Occurrence of Postoperative Gastroesophageal Reflux?

Journal of clinical gastroenterology·2026
Same journal

Subgroup Stratification by Regimen, Geography, and Population Is Necessary to Validate Nitazoxanide-based Helicobacter pylori Eradication Therapy.

Journal of clinical gastroenterology·2026
Same journal

The Impact of Glucagon-Like Peptide 1 Receptor Agonists Versus Diabetes Mellitus on Endoscopic Procedures: A Case-Control Study From a Large Tertiary Care Health System.

Journal of clinical gastroenterology·2026
See all related articles

Hyperthyroidism can cause significant liver test abnormalities, including jaundice and prolonged prothrombin time, complicating diagnosis of other liver diseases. Promptly controlling hyperthyroidism is crucial for accurate liver assessment.

Area of Science:

  • Endocrinology
  • Hepatology
  • Internal Medicine

Background:

  • Liver dysfunction is not well-characterized in hyperthyroid patients.
  • Hyperthyroidism can present with various clinical and biochemical abnormalities.

Purpose of the Study:

  • To define the spectrum of clinical and liver test abnormalities in hyperthyroid patients.
  • To investigate the impact of hyperthyroidism on liver function tests and its diagnostic implications.

Main Methods:

  • Retrospective analysis of clinical records from 43 hyperthyroid patients.
  • Categorization of patients into uncomplicated hyperthyroidism (HT), hyperthyroidism with congestive heart failure (HT/CHF), and hyperthyroidism with unrelated liver disease (HT/ULD).
  • Evaluation of clinical findings (hepatomegaly, splenomegaly, ascites) and liver function tests (aminotransferases, bilirubin, prothrombin time).

Related Experiment Videos

Main Results:

  • Hepatomegaly/splenomegaly was more frequent in HT/CHF (79%) than HT (33%) or HT/ULD (50%).
  • Severe liver test abnormalities (jaundice, prolonged prothrombin time) were observed in patients with hyperthyroidism alone or with HT/CHF.
  • No characteristic liver histology directly attributed to hyperthyroidism was identified.

Conclusions:

  • Severe liver test abnormalities can occur in hyperthyroidism, mimicking unrelated liver disease.
  • Distinguishing concomitant liver disease in hyperthyroid patients is challenging until thyroid status is normalized.
  • Management of hyperthyroidism is essential for accurate diagnosis and treatment of liver conditions.